The risks and uncertainties involved include those detailed from time to time in Ampio's filings with the Securities and Exchange Commission, including without limitation, under Ampio's Annual Report on Form 10-K, quarterly report of Form 10-Q and other documents filed with the Securities and Exchange Commission. Ampio undertakes no obligation to revise or update these forward-looking statements, whether as a result of new information, future events or otherwise. Company Contact Dan Stokely, CFO Phone: (720) 437-6500 Ampio Pharmaceuticals, Inc. AMPE SOURCE Ampio Pharmaceuticals, Inc. Related Links http://www.ampiopharma.com